On April 15, a delegation from the Xiamen Torch High-tech Zone visited the Pingshan base of Shenzhen Cell Valley Group for site inspection and business discussions, focusing on industrial coordination, technology translation, park co-development, and project implementation in the field of cell and gene therapy (CGT). The visit aimed to deepen biopharma cooperation between Fujian and Guangdong provinces, facilitating the complementary use of advantageous resources and the efficient flow of innovation factors.

    The delegation from Xiamen Torch High-tech Zone included Zheng Gonggu, General Manager of Xiamen Torch Innovation Pioneer Center; Lu Liangwei, Investment Promotion Manager; Guo Yan, Deputy General Manager of Xiamen Torch Achievement Transformation Center; Chen Xinqiang, Investment Director of Xiamen Torch High-tech Investment; and Yang Hongyuan and Bai Yaping from Purana (Xiamen) Biotechnology Co., Ltd.

    Shenzhen Cell Valley was represented by Shi Yuanyuan, Chairman and General Manager; Wang Jianxun, Chief Scientist; Wang Shaoqing, Deputy General Manager and CFO; and Wei Zheng, Administrative Director. The two sides held in-depth discussions on the company’s development strategy, technology platforms, clinical translation service system, and models for regional collaboration.

    During the visit, the delegation toured the Pingshan CGT industrial base, observing Shenzhen Cell Valley’s progress in viral vector development and production, cell manufacturing, quality control, achievement conversion, and clinical translation services. The company presented its one-stop service capabilities in the CGT field, along with its distinctive models and practical experience in advancing research outcomes toward clinical application and industrialization.

    In the symposium, the two sides explored Shenzhen Cell Valley’s clinical translation model and full-chain CDMO service system, and discussed potential cooperation on cutting-edge technologies including viral vectors, cell preparation, and results transfer. Shi Yuanyuan noted that Shenzhen Cell Valley is committed to building a comprehensive one-stop service platform for the CGT sector, continuously driving the transition of advanced technologies from R&D to clinical and industrial stages. He highlighted the solid foundations and clear advantages of Xiamen Torch High-tech Zone in technological innovation, incubation, and achievement transformation, expressing hope that the visit would serve as a starting point for strengthened communication, the establishment of a long-term, pragmatic, and efficient cooperation mechanism, and the joint promotion of high-quality project implementation and regional biopharma development.

    The visit enhanced mutual understanding between Xiamen Torch High-tech Zone and Shenzhen Cell Valley, laying a solid groundwork for broader cooperation in CGT, achievement transformation platform construction, and regional industrial synergy. Both sides agreed to continue pragmatic collaboration on key priorities, jointly injecting new momentum into biopharma innovation in Fujian and Guangdong.